Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen puts $15m into digital health alliance with TheraPanacea
Pharmaforum
Wed, 12/15/21 - 10:50 am
Tags:
Biogen, digital health, TheraPanacea, digital pharma
Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout
BioSpace
Wed, 12/8/21 - 11:52 pm
Tags:
Biogen, layoffs, Aduhelm
Biogen takes another blow as appeal for Tecfidera patent revival falls short
Fierce Pharma
Tue, 11/30/21 - 11:38 pm
Tags:
Biogen, Tecfidera, patents, multiple sclerosis, MS
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Tags:
Roche, Biogen, Alzheimer's disease, Aduhelm, gantenerumab
Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Participants
BioSpace
Mon, 11/22/21 - 10:31 pm
Tags:
Biogen, Aduhelm, brain swelling, ARIA-edema, Alzheimer's disease
Biogen seeking more information in investigation of Aduhelm patient's death
BioPharma Dive
Sat, 11/20/21 - 11:58 am
Tags:
Biogen, Aduhelm, patient deaths, Alzheimer's disease
Major Insurers Weigh in on “Medical Necessity” of Biogen’s Aduhelm
BioSpace
Sat, 11/20/21 - 11:57 am
Tags:
Biogen, Aduhelm, insurers, Alzheimer's disease
Biogen's Aduhelm 'likely' linked to Alzheimer's patient's death, RBC analyst says
Fierce Pharma
Thu, 11/18/21 - 10:58 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, patient deaths
EU steers clear of Aduhelm as a bigger headache threatens
EP Vantage
Thu, 11/18/21 - 10:33 am
Tags:
Europe, Biogen, Aduhelm, CHMP, Alzheimer's disease, Medicare
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejection
Fierce Pharma
Wed, 11/17/21 - 10:53 am
Tags:
Biogen, Europe, Aduhelm, Alzheimer's disease
Could Eli Lilly Leapfrog Biogen in This Market?
Motley Fool
Wed, 11/17/21 - 10:26 am
Tags:
Eli Lilly, Biogen, donanemab, Alzheimer's disease, Aduhelm
Biogen's research chief Alfred Sandrock to retire
Yahoo/Reuters
Mon, 11/15/21 - 11:58 pm
Tags:
Biogen, Aduhelm, R&D
Anticipating Aduhelm's costs, Medicare plans big jump in premiums
BioPharma Dive
Mon, 11/15/21 - 12:42 pm
Tags:
Medicare, Biogen, Aduhelm, Alzheimer's disease
Biogen Says Aduhelm Significantly Lowers Another Top Alzheimer's Biomarker
BioSpace
Sat, 11/13/21 - 09:53 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease
Eisai-Biogen Alzheimer's Drug Shows Amyloid Reduction, Disease-Modifying Effect
BioSpace
Thu, 11/11/21 - 10:55 am
Tags:
Eisai, Biogen, lecanemab, Alzheimer's disease, clinical trials
Biogen's Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?
Fierce Pharma
Tue, 11/9/21 - 11:52 pm
Tags:
Biogen, Aduhelm, patient deaths, Alzheimer's disease
Biogen to Present New Aduhelm Data at Upcoming Alzheimer’s Conference
BioSpace
Wed, 11/3/21 - 11:37 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, CTAD
Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm
Fierce Biotech
Tue, 10/26/21 - 10:50 am
Tags:
Eli Lilly, Alzheimer's disease, FDA, donanemab, Biogen, Aduhelm, zagotenemab
3 Big Problems With Biogen's Q3 Results
Motley Fool
Sun, 10/24/21 - 10:29 pm
Tags:
Biogen, earnings, Aduhelm
Biogen's Alzheimer's drug is struggling, and a turnaround might not be coming soon
BioPharma Dive
Wed, 10/20/21 - 06:56 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.